Literature DB >> 25230281

Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care--a Rome Foundation working team report.

A P S Hungin1, M Molloy-Bland, R Claes, J Heidelbaugh, W E Cayley, J Muris, B Seifert, G Rubin, N de Wit.   

Abstract

OBJECTIVE: To review studies on the perceptions, diagnosis and management of irritable bowel syndrome (IBS) in primary care.
METHODS: Systematic searches of PubMed and Embase.
RESULTS: Of 746 initial search hits, 29 studies were included. Relatively few primary care physicians were aware of (2-36%; nine studies) or used (0-21%; six studies) formal diagnostic criteria for IBS. Nevertheless, most could recognise the key IBS symptoms of abdominal pain, bloating and disturbed defaecation. A minority of primary care physicians [7-32%; one study (six European countries)] preferred to refer patients to a specialist before making an IBS diagnosis, and few patients [4-23%; three studies (two European, one US)] were referred to a gastroenterologist by their primary care physician. Most PCPs were unsure about IBS causes and treatment effectiveness, leading to varied therapeutic approaches and broad but frequent use of diagnostic tests. Diagnostic tests, including colon investigations, were more common in older patients (>45 years) than in younger patients [<45 years; five studies (four European, one US)].
CONCLUSIONS: There has been much emphasis about the desirability of an initial positive diagnosis of IBS. While it appears most primary care physicians do make a tentative IBS diagnosis from the start, they still tend to use additional testing to confirm it. Although an early, positive diagnosis has advantages in avoiding unnecessary investigations and costs, until formal diagnostic criteria are conclusively shown to sufficiently exclude organic disease, bowel investigations, such as colonoscopy, will continue to be important to primary care physicians.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25230281     DOI: 10.1111/apt.12957

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  14 in total

1.  Eluxadoline: a promising therapy that raises many questions.

Authors:  Brooks D Cash
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-28

2.  Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.

Authors:  Raymond Addante; Bruce Naliboff; Wendy Shih; Angela P Presson; Kirsten Tillisch; Emeran A Mayer; Lin Chang
Journal:  J Clin Gastroenterol       Date:  2019-04       Impact factor: 3.062

3.  Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Authors:  Massimo Bellini; Cesare Tosetti; Francesco Rettura; Riccardo Morganti; Christian Lambiase; Gabrio Bassotti; Pierfrancesco Visaggi; Andrea Pancetti; Edoardo Benedetto; Nicola de Bortoli; Paolo Usai-Satta; Rudi De Bastiani
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

Review 4.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

5.  Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome.

Authors:  Anton Emmanuel; Darryl Landis; Mark Peucker; A Pali S Hungin
Journal:  Frontline Gastroenterol       Date:  2016-03-07

Review 6.  Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.

Authors:  Apoorva Krishna Chandar
Journal:  Int J Gen Med       Date:  2017-10-31

7.  Knowledge and practices of primary care physicians or general practitioners treating post-infectious Irritable Bowel Syndrome.

Authors:  Erika Austhof; Kenzie Schaefer; Jaime Faulkner; Laura Bach; Mark Riddle; Kristen Pogreba-Brown
Journal:  BMC Gastroenterol       Date:  2020-05-25       Impact factor: 3.067

8.  Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway.

Authors:  Vilde Lehne Michalsen; Per Olav Vandvik; Per G Farup
Journal:  Health Qual Life Outcomes       Date:  2015-07-30       Impact factor: 3.186

9.  Gut microbiome composition and risk factors in a large cross-sectional IBS cohort.

Authors:  Melissa Agnello; Lauren N Carroll; Nabeel Imam; Rodolfo Pino; Christina Palmer; Ignacio Varas; Claire Greene; Maureen Hitschfeld; Sarah Gupta; Daniel E Almonacid; Michael C Hoaglin
Journal:  BMJ Open Gastroenterol       Date:  2020-04-06

10.  Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders.

Authors:  Ecushla C Linedale; Muhammad A Shahzad; Andrew R Kellie; Antonina Mikocka-Walus; Peter R Gibson; Jane M Andrews
Journal:  JGH Open       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.